As CEO of Quintiles, Tom Pike is driving transformation in healthcare. A powerful partner to the world’s largest biopharma companies, Quintiles is the #1 CRO for clinical trials in the world (nearly $5 billion in revenues) and touches the top 100 pharma drug launches year after year. Not to mention, its well-respected strategic consulting arm is currently partnering with Questrom’s MSMS students. You won’t want to miss this engaging conversation with Pike, who will share valuable industry insights with Ken Freeman, Allen Questrom Professor and Dean.